Back
T Rowe Price US High Yield ETF Vs. Nektar Therapeutics Industry Stock Comparison
Sell
39
THYF
T Rowe Price US High Yield ETF
Last Price:
$52.21
Seasonality Move:
-0.54%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$44.43
Seasonality Move:
6.44%
Sell
39
T Rowe Price US High Yield ETF (THYF)
is a Sell
Is T Rowe Price US High Yield ETF a Buy, Sell or Hold?
-
The current T Rowe Price US High Yield ETF [THYF] share price is $52.51. The Score for THYF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
THYF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $43.48. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
THYF Stock Price Chart
What is T Rowe Price US High Yield ETF's stock price today?
-
The T Rowe Price US High Yield ETF share price today is $52.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THYF is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $43.48Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
THYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.66 | Buy |
| Relative Strength Index (14 RSI): | 61.29 | Buy |
| Chaikin Money Flow: | -2597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.07 - 52.41) | Buy |
| Bollinger Bands (100): | (52.14 - 52.58) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.36 | Sell |
| Relative Strength Index (14 RSI): | 35.32 | Sell |
| Chaikin Money Flow: | -1120535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.64 - 61.4) | Sell |
| Bollinger Bands (100): | (35.47 - 62.69) | Sell |
THYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.4 | Buy |
| 20-day SMA: | 52.29 | Buy |
| 50-day SMA: | 52.25 | Buy |
| 200-day SMA: | 51.96 | Buy |
| 8-day EMA: | 33.25 | Buy |
| 20-day EMA: | 17.3 | Buy |
| 50-day EMA: | 7.75 | Buy |
| 200-day EMA: | 2.06 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.5 | Sell |
| 20-day SMA: | 54.97 | Sell |
| 50-day SMA: | 57.15 | Sell |
| 200-day SMA: | 31.68 | Buy |
| 8-day EMA: | 48.23 | Sell |
| 20-day EMA: | 52.53 | Sell |
| 50-day EMA: | 53.87 | Sell |
| 200-day EMA: | 38.39 | Buy |
T Rowe Price US High Yield ETF Earnings Growth & THYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
T Rowe Price US High Yield ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||